Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson’s Disease after Elimination of Heterophilic Antibody Interference

There is substantial biochemical, pathological, and genetic evidence that α-synuclein (A-syn) is a principal molecule in the pathogenesis of Parkinson disease (PD). We previously reported that total A-syn levels in cerebrospinal fluid (CSF), measured with the specific enzyme-linked immunosorbent ass...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Main Authors: Ishii, Ryotaro, Tokuda, Takahiko, Tatebe, Harutsugu, Ohmichi, Takuma, Kasai, Takashi, Nakagawa, Masanori, Mizuno, Toshiki, El-Agnaf, Omar M. A.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2015
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4388641/
https://ncbi.nlm.nih.gov/pubmed/25849645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0123162
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares